Source: Eur Respir J 2005; 25: 587-588
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sunyer J., Ulrik C. S.. Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?. Eur Respir J 2005; 25: 587-588

Member's Comments

No comment yet.

Related content which might interest you: Changes in physical activity and all-cause mortality in COPD Source: Eur Respir J 2014; 44: 1199-1209 Year: 2014 Meta-analysis of FEV1 as a risk factor for all-cause mortality Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003 Relationship between mortality risk and health status in COPD Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease Year: 2009 The natural history of COPD without co-morbidities: predictors of long-term mortality Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Tiotropium and the risk of cardiovascular events and all-cause mortality Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010 Changes in COPD-related morbidity and mortality after smoking cessation: a review Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Obesity, smoking and gender type as cardiovascular risk factors among COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 COPD-related morbidity and mortality after smoking cessation: status of the evidence Source: Eur Respir J 2008; 32: 844-853 Year: 2008 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality Source: Eur Respir J 2010; 36: 1002-1006 Year: 2010 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Gender differences in mortality risks in relation to smoking in a long-term follow-up of the Malmö preventive project Source: Eur Respir J 2003; 22: Suppl. 45, 111s Year: 2003 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Complexity of the relationship between cardiovascular co-morbidity, multi-dimensional assessment and mortality in a primary care cohort with COPD Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Age cohort mortality differences for respiratory and cardiovascular causes of death Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001